Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Encinitas. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Encinitas at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
This phase II trial studies how well olaparib works in treating patients with bladder cancer and other genitourinary tumors with deoxyribonucleic acid (DNA)-repair defects that has spread to other places in the body (advanced or metastatic) and usually cannot be cured or controlled with treatment. PARPs are proteins that help repair DNA mutations. PARP inhibitors, such as olaparib, can keep PARP from working, so tumor cells can't repair themselves, and they may stop growing.
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this bladder cancer clinical trial in Encinitas, CA
If you're searching for bladder cancer treatment options in Encinitas, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Encinitas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.